| __timestamp | Bio-Techne Corporation | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 15411924 |
| Thursday, January 1, 2015 | 40853000 | 22593274 |
| Friday, January 1, 2016 | 45187000 | 33173050 |
| Sunday, January 1, 2017 | 53514000 | 62224159 |
| Monday, January 1, 2018 | 55329000 | 95607434 |
| Tuesday, January 1, 2019 | 62413000 | 221269028 |
| Wednesday, January 1, 2020 | 65192000 | 400745069 |
| Friday, January 1, 2021 | 70603000 | 580520000 |
| Saturday, January 1, 2022 | 87140000 | 663366000 |
| Sunday, January 1, 2023 | 92493000 | 755113687 |
| Monday, January 1, 2024 | 96664000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, argenx SE and Bio-Techne Corporation have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, argenx SE's R&D expenses skyrocketed by nearly 4,800%, reflecting its aggressive pursuit of groundbreaking therapies. In contrast, Bio-Techne Corporation's R&D spending grew by approximately 212%, indicating a more measured approach.
In 2014, Bio-Techne's R&D expenses were nearly double those of argenx SE. However, by 2023, argenx SE had surpassed Bio-Techne, with R&D expenses reaching over eight times that of its 2014 figures. This shift underscores argenx SE's strategic focus on innovation, positioning it as a formidable player in the biotech industry. Notably, data for 2024 is incomplete, highlighting the dynamic nature of R&D investments.
Comparing Innovation Spending: Novo Nordisk A/S and Bio-Techne Corporation
Comparing Innovation Spending: Johnson & Johnson and Bio-Techne Corporation
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Alnylam Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and Dr. Reddy's Laboratories Limited
argenx SE or Opthea Limited: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for argenx SE and ADMA Biologics, Inc.
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Bio-Techne Corporation
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
Bio-Techne Corporation vs Iovance Biotherapeutics, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bio-Techne Corporation and Wave Life Sciences Ltd. Allocate Funds